Using this technology, scientists were able to visualize BRCA1 protein interaction in a near-native environment and gain insight into its mechanics.
The partners will try to validate the Immray PanCan-d array-based test, which looks at proteins associated with the immune response to pancreatic cancer.
The company plans to offer the immuno-MRM assays as kits covering sample prep and protein digestion as well as immuno-enrichment of specific peptides.
The group hopes to find biomarkers as a first step toward identifying or developing targeted therapeutics to avoid serious and life threatening outcomes of early lung disease in these newborns.
Fluidic Analytics, a Cambridge University spinout, has licensed the technology and plans to commercialize an instrument for the research market in mid-2016.
In Nature this week: genomic analysis of 200 bird species, and more.
The Australian High Court rules that isolated genetic material cannot be patented.
The startup incubator Y Combinator is launching a nonprofit research lab.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.